Status:
UNKNOWN
Acceptance and Commitment Therapy for Neuro-Oncology Wellbeing
Lead Sponsor:
Nottingham University Hospitals NHS Trust
Collaborating Sponsors:
University of Nottingham
University Hospitals Bristol and Weston NHS Foundation Trust
Conditions:
Brain Tumors
Quality of Life
Eligibility:
All Genders
11-24 years
Phase:
NA
Brief Summary
Background. Survivors of childhood brain tumours have the poorest health-related quality of life of all cancer survivors due to the multiple physical and psychological sequelae of brain tumours and th...
Eligibility Criteria
Inclusion
- Aged 11-to-24 years at the time of randomisation
- Received treatment for a brain tumour at a participating Principle Treatment Centre
- Active brain tumour treatment is complete and their condition stable for at least six-months
- Have sufficient cognitive ability to engage with ACT sessions as judged by the clinician at baseline assessment
- competent to provide informed consent (participants aged 16 or over) or assent (participants aged 11-15)
- Parent/carer competent to provide informed consent (for participants aged 11-15)
Exclusion
- Received a structured behavioural intervention within six-months prior to study recruitment
- Previous or current alcohol/substance dependence, psychosis, suicidality, or eating disorder
- Moderate or severe intellectual disability, confirmed through researcher judgement at screening through questions relating to school type and previous diagnoses
- Immediate risk to self or others
- The patient or their parent/carer is not able to speak, read or write English
Key Trial Info
Start Date :
March 18 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 28 2024
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04722237
Start Date
March 18 2021
End Date
June 28 2024
Last Update
August 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sophie Thomas
Nottingham, United Kingdom, NG7 2UH